Gilead Sciences's total assets for Q3 2024 were $54.52B, an increase of 1.77% from the previous quarter. GILD total liabilities were $36.13B for the fiscal quarter, a 2.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.